Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th

REDWOOD CITY, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that its second quarter 2016 financial results will be released on August 9, 2016.  At 4:30 p.m. Eastern Time, Coherus’ management will host a conference call to discuss the results for the quarter and provide a general business update.  

Financial results will be released after market close on Tuesday, August 9, 2016 and posted at http://investors.coherus.com.

Conference Call Information When: Tuesday, August 9, 2016 at 4:30 p.m. ET Dial-in: (844) 452-6826 (toll free) or (765) 507-2587 (International)  Conference ID: 46774291 Webcast:  http://investors.coherus.com Please join the conference call at least 10 minutes early to register.  The webcast will be archived on the Coherus website.

About Coherus BioSciences, Inc. Coherus is a leading global biosimilar platform company that develops and commercializes high-quality therapeutics for major regulated markets. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access. Composed of a team of proven industry veterans with world-class expertise in process science, analytical characterization, protein production and clinical-regulatory development, Coherus is positioned as a leader in the global biosimilar marketplace. Coherus is advancing three late-stage clinical products towards commercialization, CHS-1701 (pegfilgrastim biosimilar), CHS-0214 (etanercept biosimilar) and CHS-1420 (adalimumab biosimilar), as well as developing a robust pipeline of future products in four therapeutic areas, oncology, immunology (anti-TNF), ophthalmology and multiple sclerosis. For additional information, please visit www.coherus.com.

CONTACT:
Patrick O’Brien
Senior Vice President, Investor Relations
Coherus BioSciences, Inc.
[email protected]
+1 (650) 649-3527

Source: Coherus BioSciences, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
• TechnipFMC (FTI) Tops Q1 EPS by 6c, provides guidance
• Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting